Literature DB >> 10848732

Expression of Fc receptors for IgG during acute and chronic cutaneous inflammation in atopic dermatitis.

R C Kiekens1, T Thepen, I C Bihari, E F Knol, J G Van De Winkel, C A Bruijnzeel-Koomen.   

Abstract

Atopic dermatitis is an allergic skin disease characterized by elevated total and antigen-specific serum IgE and IgG4 levels. In acute and chronic cutaneous inflammation, large cellular infiltrates including T cells, dendritic cells and macrophages are found, especially in the dermis. These cells play an important part in the regulation of local inflammatory reactions. Receptors binding IgG (FcgammaR) are involved in dendritic cell and macrophage function. In this study, we examined the in vivo distribution and cellular expression of the three classes of leucocyte FcgammaR in human skin during acute and chronic cutaneous inflammation in atopic dermatitis. Atopy patch test skin was used as a model for acute inflammation in atopic dermatitis, while chronic lesional skin was used to investigate FcgammaR expression in chronically inflamed skin. In atopy patch test sites no increase in the number of CD1a+ dendritic cells and a slight increase in macrophages compared with non-lesional skin was observed. Our results showed increased expression of FcgammaRI (CD64) and FcgammaRIII (CD16) in acutely inflamed skin as well as in chronically inflamed lesional skin, compared with healthy and non-lesional atopic dermatitis skin. FcgammaRI was expressed by RFD1+, RFD7+ and CD68+, but not by CD1a+ dermal dendritic cells. RFD1+ dendritic cells and CD68+ macrophages were the main FcgammaRIII-expressing cells during the acute inflammatory reaction. The significant increase in expression of FcgammaRIII (CD16) and FcgammaRI (CD64) probably results from upregulation of the receptors on resident cells. Insight into the presence of FcgammaR+ cells in human skin during inflammation is important both for our understanding of skin immune reactions and the development of new therapeutic concepts.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10848732     DOI: 10.1046/j.1365-2133.2000.03534.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  5 in total

1.  Monitoring of basophil sensitization to antigens of the cat flea (Ctenocephalides felis felis): a new tool for the diagnosis of feline flea bite hypersensitivity?

Authors:  K Stuke; G von Samson-Himmelstjerna; J Dreesman; N Mencke; T Schnieder; W Leibold
Journal:  Parasitol Res       Date:  2008-07-02       Impact factor: 2.289

2.  Targeting CD64 mediates elimination of M1 but not M2 macrophages in vitro and in cutaneous inflammation in mice and patient biopsies.

Authors:  Dmitrij Hristodorov; Radoslav Mladenov; Verena von Felbert; Michael Huhn; Rainer Fischer; Stefan Barth; Theo Thepen
Journal:  MAbs       Date:  2015       Impact factor: 5.857

3.  Neisseria gonorrhoeae Modulates Immunity by Polarizing Human Macrophages to a M2 Profile.

Authors:  María Carolina Ortiz; Claudia Lefimil; Paula I Rodas; Rolando Vernal; Mercedes Lopez; Claudio Acuña-Castillo; Mónica Imarai; Alejandro Escobar
Journal:  PLoS One       Date:  2015-06-30       Impact factor: 3.240

4.  Activated Natural Killer Cells Mediate the Suppressive Effect of Interleukin-4 on Tumor Development via STAT6 Activation in an Atopic Condition Melanoma Model.

Authors:  Dong Ju Son; Yu Yeon Jung; Mi Hee Park; Hye Lim Lee; Min Ji Song; Hwan-Soo Yoo; Dae Youn Hwang; Sang Bae Han; Jin Tae Hong
Journal:  Neoplasia       Date:  2017-06-03       Impact factor: 5.715

5.  Non-invasive imaging of allogeneic transplanted skin graft by 131I-anti-TLR5 mAb.

Authors:  Hukui Sun; Guangjie Yang; Ting Liang; Chao Zhang; Jing Song; Jiankui Han; Guihua Hou
Journal:  J Cell Mol Med       Date:  2014-10-06       Impact factor: 5.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.